ASTHO Applauds Administration's Commitment to Combat the Opioid Epidemic ARLINGTON, VA—Michael Fraser, executive director of ASTHO, issued the following response to HHS Secretary Tom Price’s remarks at the National Rx Abuse and Heroin ...
ASTHO Celebrates 75 Years of Public Health Leadership ARLINGTON, VA—Today the Association of State and Territorial Health Officials (ASTHO) celebrates its 75th anniversary and recognizes the significant achievements of its members who have ...
ASTHO and Safe States Alliance Commit to Supporting State Injury and Violence Prevention Programs ARLINGTON, VA—The Association of State and Territorial Health Officials supports the just-released Safe States Alliance’s 2015 State of ...
ASTHO Executive Director Announces New Role at the March of Dimes ARLINGTON, VA—Association of State and Territorial Health Officials (ASTHO) Executive Director Paul E. Jarris, MD, MBA, has announced that he is stepping down at the end of ...
This episode highlights how the current equity efforts can integrate with established performance management practices.
This episode highlights COVID-19’s impact on overdose-related deaths during the postpartum period, also known as the fourth trimester. There has been a significant increase in postpartum overdose-related deaths in recent years—a problem ...
If there’s anyone who has spent their career preparing for a global pandemic, it’s Anne Schuchat, MD. Currently, she serves as the principal deputy director of the Centers for Disease Control and Prevention (CDC). She sat down with ASTHO ...
This episode discusses why there needs to be a comprehensive response in public health surveillance, in particular around the opioid epidemic. After all, without thorough data, it’s tough for lawmakers to drive action that will reduce the ...
Sepsis is a life-threatening condition caused by the body’s extreme response to an infection, it can rapidly lead to tissue damage, organ failure, and death. Our guests on this episode discuss the importance of sepsis protocols at ...
Medicaid and public health partnerships play an important role in advancing a statewide approach to addressing chronic disease and population health. Collaboration and shared priorities between agencies play a significant role in ...
Co-authors from CDC and the Alzheimer’s Association provide details about the new 2018-2023 Healthy Brain Initiative Road Map, which offers strategies for public health agencies to promote cognitive health and support people living with ...
In the Public Health Review podcast debut, host Robert Johnson speaks with public health officials from Alaska, Kentucky, and West Virginia about the ongoing opioid epidemic in the U.S. and its intersections with other epidemics like ...
Dr. Brian Castrucci, de Beaumont Foundation President and CEO, discusses the concerning results of the latest PH WINS Survey of nearly 45,000 public health workers across the nation; ASTHO is teaming with the Association of Maternal and ...
In this ASTHO webinar, learn how state public health agencies can align with state Medicaid agencies to collaboratively advance the goals of the National Ending the HIV Initiative. Featured guests include the Virginia Department of Medical ...
Infodemic Management This training covers the process that CDC uses to assess social listening and other data for the State of Vaccine Confidence Insights Reports and how you can adopt a similar process to inform action. Speakers Claire ...
This article in Journal of Public Health Management & Practice discusses ASTHO's strategies for reducing maternal mortality and morbidity.
This article in Journal Of Women's Health explores the actions of jurisdictions that participated in the Increasing Access to Contraception Learning Community, and how they continued the work of their action plan goals 1 year after the ...
This article in Journal of Maternal and Child Health demonstrates the application of implementation science methodology to study the complexities of rolling-out policies that promote immediate postpartum long-acting reversible ...
Maximizing the Benefit of COVID-19 Therapeutics: Considerations for State Public Health Officials